CTLA4 and cancer: Consistent with these findings, Escherichia has been associated with promotion of colorectal and other cancers (Dalmasso et al., 2014), while Akkermansia has been linked to the potentiation of anti-CTLA-4 and anti-PD-1 immunotherapy (Miller and Carson, 2020).